Bellicum Pharmaceuticals (NASDAQ:BLCM) is up 6.6% after hours following an SEC filing disclosing Baker Bros. taking a 5.8% stake.
That makes them the second-largest shareholder in the company, Bloomberg says.
Aggregate purchase price of the securities directly held by the affiliated funds was about $80.7M.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.